213 related articles for article (PubMed ID: 3049910)
1. Synthesis and release of platelet-activating factor is inhibited by plasma alpha 1-proteinase inhibitor or alpha 1-antichymotrypsin and is stimulated by proteinases.
Camussi G; Tetta C; Bussolino F; Baglioni C
J Exp Med; 1988 Oct; 168(4):1293-306. PubMed ID: 3049910
[TBL] [Abstract][Full Text] [Related]
2. Involvement of a serine protease in the synthesis of platelet-activating factor by endothelial cells stimulated by tumor necrosis factor-alpha or interleukin-1 alpha.
Bussolino F; Arese M; Silvestro L; Soldi R; Benfenati E; Sanavio F; Aglietta M; Bosia A; Camussi G
Eur J Immunol; 1994 Dec; 24(12):3131-9. PubMed ID: 7805742
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor.
Camussi G; Bussolino F; Salvidio G; Baglioni C
J Exp Med; 1987 Nov; 166(5):1390-404. PubMed ID: 3119758
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor stimulates human neutrophils to release leukotriene B4 and platelet-activating factor. Induction of phospholipase A2 and acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine O2-acetyltransferase activity and inhibition by antiproteinase.
Camussi G; Tetta C; Bussolino F; Baglioni C
Eur J Biochem; 1989 Jul; 182(3):661-6. PubMed ID: 2546764
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin 1 alpha.
Bussolino F; Camussi G; Baglioni C
J Biol Chem; 1988 Aug; 263(24):11856-61. PubMed ID: 3261295
[TBL] [Abstract][Full Text] [Related]
6. Platelet-activating factor biosynthesis by cultured mesangial cells is modulated by proteinase inhibitors.
Biancone L; Tetta C; Turello E; Montrucchio G; Iorio EL; Servillo L; Balestrieri C; Camussi G
J Am Soc Nephrol; 1992 Jan; 2(7):1251-61. PubMed ID: 1591364
[TBL] [Abstract][Full Text] [Related]
7. Selected cytokines promote the synthesis of platelet-activating factor in vascular endothelial cells: comparison between tumor necrosis factor alpha and beta and interleukin-1.
Bussolino F; Camussi G; Tetta C; Garbarino G; Bosia A; Baglioni C
J Lipid Mediat; 1990; 2 Suppl():S15-22. PubMed ID: 2133280
[TBL] [Abstract][Full Text] [Related]
8. Endothelial cell associated platelet-activating factor (PAF), a costimulatory intermediate in TNF-alpha-induced H2O2 release by adherent neutrophil leukocytes.
von Asmuth EJ; Buurman WA
J Immunol; 1995 Feb; 154(3):1383-90. PubMed ID: 7529802
[TBL] [Abstract][Full Text] [Related]
9. Detachment of cultured normal human keratinocytes by contact with TNF alpha-stimulated neutrophils in the presence of platelet-activating factor.
Katayama H; Hase T; Yaoita H
J Invest Dermatol; 1994 Aug; 103(2):187-90. PubMed ID: 7913720
[TBL] [Abstract][Full Text] [Related]
10. IL-1-induced adhesion of polymorphonuclear leukocytes to cultured human endothelial cells. Role of platelet-activating factor.
Breviario F; Bertocchi F; Dejana E; Bussolino F
J Immunol; 1988 Nov; 141(10):3391-7. PubMed ID: 3263425
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and release of platelet-activating factor and eicosanoids in human endothelial cells induced by different agonists.
Cabré F; Tost D; Suesa N; Gutiérrez M; Ucedo P; Mauleón D; Carganico G
Agents Actions; 1993 Mar; 38(3-4):212-9. PubMed ID: 8213348
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil-activating activity and platelet-activating factor synthesis in cytokine-stimulated endothelial cells: reduced activity in growth-arrested cells.
Takahashi T; Nishizawa Y; Hato F; Shintaku H; Maeda N; Fujiwara N; Inaba M; Kobayashi K; Kitagawa S
Microvasc Res; 2007 Jan; 73(1):29-34. PubMed ID: 17027041
[TBL] [Abstract][Full Text] [Related]
13. Meconium enhances platelet-activating factor and tumor necrosis factor production by rat alveolar macrophages.
Berdeli A; Akisu M; Dagci T; Akisu C; Yalaz M; Kultursay N
Prostaglandins Leukot Essent Fatty Acids; 2004 Oct; 71(4):227-32. PubMed ID: 15301793
[TBL] [Abstract][Full Text] [Related]
14. Cytokine-induced monocyte adhesion to endothelial cells involves platelet-activating factor: suppression by conjugated linoleic acid.
Sneddon AA; McLeod E; Wahle KW; Arthur JR
Biochim Biophys Acta; 2006 Jul; 1761(7):793-801. PubMed ID: 16829183
[TBL] [Abstract][Full Text] [Related]
15. Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling intercellular adhesion.
Zimmerman GA; McIntyre TM; Mehra M; Prescott SM
J Cell Biol; 1990 Feb; 110(2):529-40. PubMed ID: 2153685
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha enhances platelet activation via cathepsin G released from neutrophils.
Renesto P; Chignard M
J Immunol; 1991 Apr; 146(7):2305-9. PubMed ID: 2005399
[TBL] [Abstract][Full Text] [Related]
17. Biphasic platelet-activating factor synthesis by human monocytes stimulated with IL-1-beta, tumor necrosis factor, or IFN-gamma.
Valone FH; Epstein LB
J Immunol; 1988 Dec; 141(11):3945-50. PubMed ID: 3141509
[TBL] [Abstract][Full Text] [Related]
18. In vivo catabolism of alpha 1-antichymotrypsin is mediated by the Serpin receptor which binds alpha 1-proteinase inhibitor, antithrombin III and heparin cofactor II.
Pizzo SV; Mast AE; Feldman SR; Salvesen G
Biochim Biophys Acta; 1988 Nov; 967(2):158-62. PubMed ID: 3263884
[TBL] [Abstract][Full Text] [Related]
19. Regulation of platelet-activating factor synthesis by acetyl-coenzyme A.
Tetta C; Camussi G; Bussolino F; Baglioni C
J Lipid Mediat; 1990; 2 Suppl():S55-63. PubMed ID: 1966818
[TBL] [Abstract][Full Text] [Related]
20. Endothelial cell-associated platelet-activating factor primes neutrophils for enhanced superoxide production and arachidonic acid release during adhesion to but not transmigration across IL-1 beta-treated endothelial monolayers.
Hill ME; Bird IN; Daniels RH; Elmore MA; Finnen MJ
J Immunol; 1994 Oct; 153(8):3673-83. PubMed ID: 7930587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
